Chester County News and Community Website
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced the first patient has been dosed in its Phase 3 liMeliGhT clinical trial for OCU400, a gene therapy candidate for retinitis pigmentosa …
Ocugen Doses First Patient in Phase 3 Trial for Retinitis Pigmentosa Therapy Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …
FDA Approves New Treatment for Advanced Endometrial Cancer Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved blinatumomab (Blincyto, Amgen Inc.) for both adult and pediatric patients one month and older with CD19-positive Philadelphia chromosome-negative …
FDA Approves Blinatumomab for Advanced Leukemia Treatment Read More
WASHINGTON, D.C. — The Biomedical Advanced Research and Development Authority (BARDA) has announced up to $500 million in funding under Project NextGen to advance clinical trials of novel COVID-19 vaccines …
BARDA Allocates $500 Million for Innovative COVID-19 Vaccine Trials Read More
MALVERN, PA — Almirall announced that the U.S. Food and Drug Administration (FDA) recently approved an expansion for its drug Klisyri, allowing it to be used over a larger surface …
FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment Read More
WASHINGTON, D.C. — Syphilis rates in the United States have surged over the past decade, affecting all populations. In response, the Department of Health and Human Services (HHS) has formed …
HHS Task Force Addresses Rising Syphilis Rates with New Testing Guidelines Read More
PLYMOUTH MEETING, PA — A clinical evidence assessment by ECRI, a global patient safety organization, found that cranial electrical stimulation (CES) can effectively relieve anxiety symptoms. The treatment outperformed placebo …
Study Finds Cranial Electrical Stimulation Effective for Anxiety Relief Read More
PLYMOUTH MEETING, PA — New research published in the June 2024 issue of the Journal of the National Comprehensive Cancer Network (JNCCN) highlights a promising approach to improving the well-being …
Positive Psychology Program Shows Promise for Blood Cancer Patients Post-Transplant Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a warning about a multistate outbreak of Salmonella infections connected to bearded dragons. The outbreak has affected …
CDC Warns of Salmonella Outbreak Linked to Bearded Dragons Read More